Capital Research Global Investors 13D and 13G filings for Gilead Sciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-13 3:32 pm Sale |
2023-02-14 | 13G | Gilead Sciences, Inc. GILD |
Capital Research Global Investors | 54,602,952 4.400% |
-52,554,029 (-49.04%) |
Filing |
| 2022-02-11 12:22 pm Sale |
2022-02-14 | 13G | Gilead Sciences, Inc. GILD |
Capital Research Global Investors | 107,156,981 8.500% |
-14,515,418 (-11.93%) |
Filing |
| 2021-02-16 3:46 pm Unchanged |
2021-02-16 | 13G | Gilead Sciences, Inc. GILD |
Capital Research Global Investors | 121,672,399 9.700% |
0 (Unchanged) |
Filing |
| 2021-02-16 1:27 pm Purchase |
2021-02-16 | 13G | Gilead Sciences, Inc. GILD |
Capital Research Global Investors | 121,672,399 9.700% |
36,539,514 (+42.92%) |
Filing |